CX Institutional lifted its position in Rocket Lab Corporation (NASDAQ:RKLB – Free Report) by 52,312.8% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 126,839 shares of the rocket manufacturer’s stock after buying an additional 126,597 shares during the period. CX Institutional’s holdings in Rocket Lab were worth $8,838,000 as of its most recent SEC filing.
Other hedge funds also recently added to or reduced their stakes in the company. BlackRock Inc. bought a new position in Rocket Lab during the 2nd quarter worth about $4,124,970,000. Bank of New York Mellon Corp purchased a new stake in shares of Rocket Lab in the 2nd quarter worth approximately $245,764,000. Bank of America Corp DE purchased a new stake in shares of Rocket Lab in the 2nd quarter worth approximately $437,280,000. Capital World Investors boosted its stake in shares of Rocket Lab by 12.0% during the fourth quarter. Capital World Investors now owns 16,200,726 shares of the rocket manufacturer’s stock valued at $1,130,172,000 after purchasing an additional 1,738,623 shares in the last quarter. Finally, Legal & General Group Plc bought a new position in shares of Rocket Lab during the second quarter valued at approximately $171,763,000. 71.78% of the stock is owned by hedge funds and other institutional investors.
Rocket Lab Stock Up 4.9%
RKLB traded up $3.46 during trading on Friday, hitting $73.92. The stock had a trading volume of 26,727,281 shares, compared to its average volume of 23,093,701. The company has a market capitalization of $44.23 billion, a PE ratio of -273.77 and a beta of 2.93. Rocket Lab Corporation has a twelve month low of $37.57 and a twelve month high of $151.00. The company has a debt-to-equity ratio of 0.01, a quick ratio of 4.98 and a current ratio of 5.48. The stock has a 50 day simple moving average of $69.57 and a two-hundred day simple moving average of $84.41.
Insider Activity
In other Rocket Lab news, SVP Arjun Kampani sold 7,754 shares of the firm’s stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $69.63, for a total value of $539,911.02. Following the completion of the sale, the senior vice president owned 256,951 shares of the company’s stock, valued at approximately $17,891,498.13. This trade represents a 2.93% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Marvin Clevenger sold 15,051 shares of the business’s stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $69.63, for a total value of $1,048,001.13. Following the sale, the insider owned 458,924 shares in the company, valued at $31,954,878.12. The trade was a 3.18% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 3,676,528 shares of company stock worth $313,368,560 over the last quarter. Company insiders own 8.40% of the company’s stock.
Analyst Ratings Changes
RKLB has been the subject of a number of analyst reports. Piper Sandler initiated coverage on Rocket Lab in a report on Wednesday, July 15th. They set a “neutral” rating and a $83.00 target price for the company. Cantor Fitzgerald reiterated an “overweight” rating on shares of Rocket Lab in a report on Monday, September 21st. Berenberg Bank assumed coverage on Rocket Lab in a research report on Wednesday, September 2nd. They issued a “buy” rating and a $83.00 price target for the company. Citigroup started coverage on Rocket Lab in a research report on Thursday. They set a “buy” rating and a $105.00 price objective on the stock. Finally, KGI Securities upgraded Rocket Lab from a “neutral” rating to an “outperform” rating and set a $107.00 target price on the stock in a research note on Monday, July 27th. Four analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $107.20.
View Our Latest Stock Report on Rocket Lab
Key Rocket Lab News
Here are the key news stories impacting Rocket Lab this week:
- Positive Sentiment: Record Synspective contract: Rocket Lab signed a multi-year agreement for 20 Electron launches between 2028 and 2031. The deal lifts Synspective’s total planned missions to 47 and pushes Rocket Lab’s launch backlog above 100 missions, strengthening visibility for future launch revenue. Rocket Lab’s 20-Launch Synspective Deal Pushes Backlog Above 100 Missions
- Positive Sentiment: Wall Street support: Citi initiated coverage with a Buy rating and a $105 price target, calling RKLB a potential “core holding for space bulls.” Other analysts cited in recent coverage see substantial upside, supporting the stock’s rebound. Rocket Lab Stock Rises on Record Electron Launch Deal and Citi Buy Rating
- Positive Sentiment: Institutional buying: Cathie Wood’s ARK Invest ETFs reportedly purchased more than $41 million of Rocket Lab shares across ARKK, ARKQ and ARKX. The buying reflects confidence in Electron, the company’s space-systems business and its planned Neutron rocket. Cathie Wood Is Buying Rocket Lab Again
- Neutral Sentiment: Competitive backdrop: SpaceX’s successful Starship orbital test highlights both the opportunity and the threat for Rocket Lab. Larger, potentially lower-cost rockets could pressure launch economics, increasing the importance of Rocket Lab’s differentiated, dedicated-launch strategy and Neutron’s development.
- Negative Sentiment: Risks remain: The Synspective contract’s financial terms were not disclosed, Rocket Lab remains unprofitable, and its latest reported quarter missed the consensus EPS estimate despite exceeding revenue expectations. Extensive insider selling—including sales by CEO Peter Beck—may also weigh on sentiment and raises valuation concerns after the recent rally.
About Rocket Lab
Rocket Lab USA, Inc is a space and launch company that provides launch services, spacecraft, satellite components and other space systems for commercial, civil and national-security customers. The company designs and manufactures many of its products in-house, supporting missions from initial spacecraft development through launch and on-orbit operations.
Rocket Lab’s primary launch vehicle is Electron, a small-lift rocket designed to place satellites into low Earth orbit. The company also operates the HASTE suborbital test platform for hypersonic and other advanced aerospace technologies and is developing Neutron, a larger reusable rocket intended to serve commercial and government missions.
Further Reading
- Five stocks we like better than Rocket Lab
- AST SpaceMobile’s BlueBird Progress Comes With Several Risks Still Unresolved
- Time to Nibble on MCD Stock After it Enters Oversold Territory?
- McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal Upside
- Corning and AT&T’s $3 Billion Fiber Deal Reveals Where AI Spending Goes Next
Want to see what other hedge funds are holding RKLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rocket Lab Corporation (NASDAQ:RKLB – Free Report).
Receive News & Ratings for Rocket Lab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rocket Lab and related companies with MarketBeat.com's FREE daily email newsletter.
